EDAP TMS S.A

EDAP TMS S.A. together with its subsidiaries develops produces markets distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia France the United States and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU) Extracorporeal ShockWave Lithotripsy (ESWL) and Distribution Services (DIST). The HIFU segment develops manufactures and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software which merges MRI and ultrasound images; and the Focal One a HIFU robotic device dedicated to the focal therapy of prostate cancer as well as disposables and leasing and treatment related services; and maintenance services. The ESWL division manufactures markets and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move an extracorporeal shockwave lithotripter to small and mid-size hospitals as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets distributes and services lasers micro-ultrasound systems and other medical products from third parties as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing sales organization and service platform as well as through third-party distributors and agents. The company serves hospitals urology clinics and research institutions. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Lyon France.